https://pkr-signal.com/index.p....hp/building-involvin
In Crohn's disease (CD), the ability to identify patients with a high likelihood of a disabling disease course would be highly beneficial to guiding the initial treatment strategy. We undertook a study to determine how clinical, serological, and genetic indicators might influence and predict a severe course in children with Crohn's disease. From the EPIMAD population-based registry, data were collected for pediatric-